Indirect regulation of human dehydroepiandrosterone sulfotransferase family 1A member 2 by thyroid hormones

Endocrinology

Volumn 147, Issue 5, 2006, Pages 2481-2489

  Huang, Ya Hui ^a   Lee, Chih Yi ^a   Tai, Pei Ju ^a   Yen, Chun Che ^a   Liao, Chu Yu ^a   Chen, Wei Jan ^b   Liao, Cheng Jung ^a   Cheng, Wan Li ^a   Chen, Ruey Nan ^a   Wu, Sheng Ming ^a   Wang, Chia Siu ^b   Lin, Kwang Huei ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLOHEXIMIDE; DEHYDROEPIANDROSTERONE SULFONTRANSFERASE 2A1; LIOTHYRONINE; MESSENGER RNA; PRASTERONE; STEROIDOGENIC FACTOR 1; SULFOTRANSFERASE; THYROID HORMONE; THYROID HORMONE RECEPTOR ALPHA; TRANSCRIPTION FACTOR GATA 6; UNCLASSIFIED DRUG;

ADRENAL GLAND; ARTICLE; BINDING SITE; CONTROLLED STUDY; DELETION MUTANT; DNA MICROARRAY; ENZYME INHIBITION; GENE DELETION; GENE EXPRESSION; GENE TARGETING; GENETIC REGULATION; HEPATOMA CELL; HUMAN; HUMAN CELL; MALE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; REPORTER GENE; THYROIDECTOMY; UPREGULATION;

ANIMALS; BINDING SITES; BLOTTING, NORTHERN; CELL LINE; CELL NUCLEUS; CLONING, MOLECULAR; CYCLOHEXIMIDE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOBLOTTING; MALE; MODELS, GENETIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; SULFOTRANSFERASES; THYROID HORMONES; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 33645845152     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1166     Document Type: Article

References (44)

1. Privalsky ML 2004 The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 66:315-360
2. Zhang J, Lazar MA 2000 The mechanism of action of thyroid hormones. Annu Rev Physiol 62:439-466
3. Yen PM 2001 Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142
4. Wu Y, Xu B, Koenig RJ 2001 Thyroid hormone response element sequence and the recruitment of retinoid X receptors for thyroid hormone responsiveness. J Biol Chem 276:3929-3936
5. Li J, Wang J, Nawaz Z, Liu JM, Qin J, Wong J 2000 Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J 19:4342-4350
6. Cohen RN, Putney A, Wondisford FE, Hollenberg AN 2000 The nuclear corepressors recognize distinct nuclear receptor complexes. Mol Endocrinol 14:900-914
7. Sande S, Privalsky ML 1996 Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol Endocrinol 10:813-825
8. Ding XF, Anderson CM, Ma H, Hong H, Uht RM, Kushner PJ, Stallcup MR 1998 Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol Endocrinol 12:302-313
9. Bhat MK, Yu C, Yap N, Zhan Q, Hayashi Y, Seth P, Cheng S 1997 Tumor suppressor p53 is a negative regulator in thyroid hormone receptor signaling pathways. J Biol Chem 272:28989-28993
10. Nagata K, Yamazoe Y 2000 Pharmacogenetics of sulfotransferase. Annu Rev Pharmacol Toxicol 40:159-176
11. Seely J, Amigh KS, Suzuki T, Mayhew B, Sasano H, Giguere V, Laganiere J, Carr BR, Rainey WE 2005 Transcriptional regulation of dehydroepiandrosterone sulfotransferase (SULT2A1) by estrogen-related receptor α. Endocrinology 146:3605-3613
12. Duanmu Z, Locke D, Smigelski J, Wu W, Dahn MS, Falany CN, Kocarek TA, Runge-Morris M 2002 Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug Metab Dispos 30:997-1004
13. Falany CN, Comer KA, Dooley TP, Glatt H 1995 Human dehydroepiandrosterone sulfotransferase. Purification, molecular cloning, and characterization. Ann NY Acad Sci 774:59-72
14. Glatt H, Pauly K, Czich A, Falany JL, Falany CN 1995 Activation of benzylic alcohols to mutagens by rat and human sulfotransferases expressed in Escherichia coli. Eur J Pharmacol 293:173-181
15. Falany CN 1997 Enzymology of human cytosolic sulfotransferases. FASEB J 11:206-216
16. Falany CN 1997 Sulfation and sulfotransferases. Introduction: changing view of sulfation and the cytosolic sulfotransferases. FASEB J 11:1-2
17. Chen G, Zhang D, Jing N, Yin S, Falany CN, Radominska-Pandya A 2003 Human gastrointestinal sulfotransferases: identification and distribution. Toxicol Appl Pharmacol 187:186-197
18. Chu XY, Huskey SE, Braun MP, Sarkadi B, Evans DC, Evers R 2004 Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3. J Pharmacol Exp Ther 309:156-164
19. Lin KH, Lin YW, Parkison C, Cheng SY 1994 Stimulation of proliferation by 3,3′,5-triiodo-L-thyronine in poorly differentiated human hepatocarcinoma cells overexpressing β1 thyroid hormone receptor. Cancer Lett 85:189-194
20. Chamba A, Neuberger J, Strain A, Hopkins J, Sheppard MC, Franklyn JA 1996 Expression and function of thyroid hormone receptor variants in normal and chronically diseased human liver. J Clin Endocrinol Metab 81:360-367
21. Shih CH, Chen SL, Yen CC, Huang YH, Chen CD, Lee YS, Lin KH 2004 Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 145:2804-2814
22. Lin KH, Shieh HY, Hsu HC 2000 Negative regulation of the antimetastatic gene Nm23-H1 by thyroid hormone receptors. Endocrinology 141:2540-2547
23. Samuels HH, Stanley F, Casanova J 1979 Depletion of l-3,5,3′-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105:80-85
24. Lin KH, Chen CY, Chen SL, Yen CC, Huang YH, Shih CH, Shen JJ, Yang RC, Wang CS 2004 Regulation of fibronectin by thyroid hormone receptors. J Mol Endocrinol 33:445-458
25. Lin KH, Wang WJ, Wu YH, Cheng SY 2002 Activation of antimetastatic Nm23-H1 gene expression by estrogen and its α-receptor. Endocrinology 143:467-475
26. Sambrook J, Russell DW 2001 Molecular cloning: a laboratory manual. In: Russell SA, ed. Extraction, purification, and analysis of mRNA from eukaryotic cells. 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 7.4 -7.75
27. Saner KJ, Suzuki T, Sasano H, Pizzey J, Ho C, Strauss 3rd JF, Carr BR, Rainey WE 2005 Steroid sulfotransferase 2A1 gene transcription is regulated by steroidogenic factor 1 and GATA-6 in the human adrenal. Mol Endocrinol 19:184-197
28. Hsu LC, Liu S, Abedinpour F, Beech RD, Lahti JM, Kidd VJ, Greenspan JA, Yeung CY 2003 The murine G+C-rich promoter binding protein mGPBP is required for promoter-specific transcription. Mol Cell Biol 23:8773-8785
29. Yang H, Yuan P, Wu V, Tache Y 1999 Feedback regulation of thyrotropin-releasing hormone gene expression by thyroid hormone in the caudal raphe nuclei in rats. Endocrinology 140:43-49
30. Baur A, Kohrle J 1999 Type 1 deiodinase is stimulated by iodothyronines and involved in thyroid hormone metabolism in human somatomammotroph GX cells. Eur J Endocrinol 140:367-370
31. Rainey WE, Carr BR, Sasano H, Suzuki T, Mason JI 2002 Dissecting human adrenal androgen production. Trends Endocrinol Metab 13:234-239
32. Zbella EA, Ilekis J, Scommegna A, Benveniste R 1986 Competitive studies with dehydroepiandrosterone sulfate and 16 α-hydroxydehydroepiandrosterone sulfate in cultured human choriocarcinoma JEG-3 cells: effect on estrone, 17β-estradiol, and estriol secretion. J Clin Endocrinol Metab 63:751-757
33. Visser TJ, van Buuren JCJ, Rutgers M, Eelkman Rooda SJ, de Herder WW 1990 The role of sulfation in thyroid hormone metabolism. Trends Endocr Metab:211-218
34. Visser TJ 1994 Role of sulfation in thyroid hormone metabolism. Chem Biol Interact 92:293-303
35. Hollenberg AN, Monden T, Flynn TR, Boers ME, Cohen O, Wondisford FE 1995 The human thyrotropin-releasing hormone gene is regulated by thyroid hormone through two distinct classes of negative thyroid hormone response elements. Mol Endocrinol 9:540-550
36. Maglich JM, Watson J, McMillen PJ, Goodwin B, Willson TM, Moore JT 2004 The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J Biol Chem 279:19832-19838
37. Qatanani M, Zhang J, Moore DD 2005 Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism. Endocrinology 146:995-1002
38. Fang HL, Strom SC, Cai H, Falany CN, Kocarek TA, Runge-Morris M 2005 Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor α transcription factor. Mol Pharmacol 67:1257-1267
39. Echchgadda I, Song CS, Roy AK, Chatterjee B 2004 Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol Pharmacol 65:720-729
40. Song CS, Echchgadda I, Baek BS, Ahn SC, Oh T, Roy AK, Chatterjee B 2001 Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor. J Biol Chem 276:42549-42556
41. Maiti S, Chen X, Chen G 2005 All-trans retinoic acid induction of sulfotransferases. Basic Clin Pharmacol Toxicol 96:44-53
42. Sonoda J, Xie W, Rosenfeld JM, Barwick JL, Guzelian PS, Evans RM 2002 Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci USA 99:13801-13806
43. Song CS, Jung MH, Kim SC, Hassan T, Roy AK, Chatterjee B 1998 Tissue-specific and androgen-repressible regulation of the rat dehydroepiandrosterone sulfotransferase gene promoter. J Biol Chem 273:21856-21866
44. Tagawa N, Tamanaka J, Fujinami A, Kobayashi Y, Takano T, Fukata S, Kuma K, Tada H, Amino N 2000 Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism. Clin Chem 46:523-528